Literature DB >> 2569677

Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat.

L A Carr1, P P Rowell, W M Pierce.   

Abstract

Nicotine was administered acutely and subchronically (14 days) to determine whether various synaptic mechanisms are selectively altered in the nigrostriatal and mesolimbic dopaminergic systems in the rat. When added to tissue preparations in vitro, nicotine had no effects on tyrosine hydroxylase, synaptosomal uptake of [3H]dopamine or binding of [3H]spiperone to D2 receptors in either system. However, acute treatment in vivo stimulated tyrosine hydroxylase activity in the nucleus accumbens. This effect was prevented by pretreatment with a nicotinic antagonist, suggesting that it was mediated by nicotinic receptors. Since subchronic exposure to nicotine had no effect on tyrosine hydroxylase, it appears that tolerance develops to this action. In vivo treatment with nicotine did not alter dopamine uptake or receptor binding. The results suggest that, in doses which result in moderate plasma levels, nicotine has selective stimulant actions on nerve terminals of the mesolimbic system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569677     DOI: 10.1007/BF00964911

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  The effect of nicotine on central catecholamine neurons and gonadotropin secretion. I. Studies in the male rat.

Authors:  K Fuxe; L Agnati; P Eneroth; J A Gustafsson; T Hökfelt; A Löfström; B Skett; P Skett
Journal:  Med Biol       Date:  1977-06

2.  Acute effect of nicotine on the striatal dopaminergic system in the rat.

Authors:  Y K Fung; Y S Lau
Journal:  J Pharm Pharmacol       Date:  1986-12       Impact factor: 3.765

3.  Effects of single injections of nicotine on the ascending dopamine pathways in the rat. Evidence for increases of dopamine turnover in the mesostriatal and mesolimbic dopamine neurons.

Authors:  K Andersson; K Fuxe; L F Agnati
Journal:  Acta Physiol Scand       Date:  1981-07

4.  Nicotine-induced release of catecholamines from rat hippocampus and striatum.

Authors:  L Arqueros; D Naquira; E Zunino
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

5.  Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat.

Authors:  G Singer; M Wallace; R Hall
Journal:  Pharmacol Biochem Behav       Date:  1982-09       Impact factor: 3.533

6.  Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.

Authors:  M J Marks; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1985-02       Impact factor: 3.533

7.  Nicotine pharmacokinetics and its application to intake from smoking.

Authors:  C Feyerabend; R M Ings; M A Russel
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

8.  Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain.

Authors:  D G Kirch; G A Gerhardt; R C Shelton; R Freedman; R J Wyatt
Journal:  Clin Neuropharmacol       Date:  1987-08       Impact factor: 1.592

9.  Mecamylamine induced blockade of nicotine induced inhibition of gonadotrophin and TSH secretion and of nicotine induced increases of catecholamine turnover in the rat hypothalamus.

Authors:  K Andersson; K Fuxe; P Eneroth; J A Gustafsson; L F Agnati
Journal:  Acta Physiol Scand Suppl       Date:  1980

10.  Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.

Authors:  M J Marks; J A Stitzel; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

View more
  11 in total

1.  Region-specific transcriptional response to chronic nicotine in rat brain.

Authors:  J K Kane; T Barrett; M P Vawter; R Chang; J Z Ma; D M Donovan; B Sharp; K G Becker; M D Li
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

2.  Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats.

Authors:  Samuel S Shin; Eric R Bray; C Edward Dixon
Journal:  J Neurotrauma       Date:  2011-10-24       Impact factor: 5.269

3.  Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism.

Authors:  Lisa S Middleton; Subbu Apparsundaram; Kelley A King-Pospisil; Linda P Dwoskin
Journal:  Eur J Pharmacol       Date:  2006-10-19       Impact factor: 4.432

4.  Ibogaine and the dopaminergic response to nicotine.

Authors:  I M Maisonneuve; G L Mann; C R Deibel; S D Glick
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

5.  Gestational nicotine exposure regulates expression of AMPA and NMDA receptors and their signaling apparatus in developing and adult rat hippocampus.

Authors:  H Wang; M I Dávila-García; W Yarl; M C Gondré-Lewis
Journal:  Neuroscience       Date:  2011-05-12       Impact factor: 3.590

6.  Nicotinic receptor activation increases [3H]dopamine uptake and cell surface expression of dopamine transporters in rat prefrontal cortex.

Authors:  Jun Zhu; Subbu Apparsundaram; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2008-12-16       Impact factor: 4.030

Review 7.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

Review 8.  Animal models and treatments for addiction and depression co-morbidity.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

9.  Fetal nicotine exposure increases preference for nicotine odor in early postnatal and adolescent, but not adult, rats.

Authors:  Nicole M Mantella; Paul F Kent; Steven L Youngentob
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

10.  No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT.

Authors:  Gerda Thomsen; Gitte Moos Knudsen; Peter S Jensen; Morten Ziebell; Klaus K Holst; Susanne Asenbaum; Jan Booij; Jacques Darcourt; John C Dickson; Ozlem L Kapucu; Flavio Nobili; Osama Sabri; Terez Sera; Klaus Tatsch; Livia Tossici-Bolt; Koen Van Laere; Thierry Vander Borght; Andrea Varrone; Marco Pagani; Lars Hageman Pinborg
Journal:  EJNMMI Res       Date:  2013-05-20       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.